Q

What are the implications of the TAME trial regarding Metformin and longevity?

From 5 years of verified research · Vassili Sandqvist
A

The TAME trial seeks to investigate whether Metformin's effects on AMPK activation, mTOR inhibition, and inflammation can replicate the metabolic benefits of caloric restriction, which is known to extend healthspan. Preliminary epidemiological data suggests that diabetic patients on Metformin experience lower cancer rates and potentially greater longevity compared to those on other medications.

This is one answer. The complete system — the psychology, the biology, and the method — is in the book.

Read The Willpower Lie →
Found an error? Let me know →